Literature DB >> 20456085

Clinical trials in youth with type 2 diabetes.

Julie Anne L Gemmill1, Rebecca J Brown, Radha Nandagopal, Luisa M Rodriguez, Kristina I Rother.   

Abstract

Type 2 diabetes in youth was almost unheard of only two decades ago. However, tracking the recent dramatic rise in childhood obesity, type 2 diabetes has become increasingly prevalent. Thus, there is an urgent need for high-quality clinical trials to increase in-depth knowledge about pathophysiology, optimal treatment, and prevention. We therefore systematically reviewed published and ongoing clinical trials of type 2 diabetes in children and adolescents. The results demonstrate that (i) few randomized clinical trials have been completed and published in children with type 2 diabetes; (ii) ongoing trials in type 1 diabetes clearly outnumber trials in type 2 diabetes; and (iii) recruitment and enrollment into the latter trials are challenging, however once achieved, drop-out rates are not excessively high. We conclude that type 2 diabetes in youth is an important but difficult new field of clinical research, and we discuss the existing barriers to successful recruitment, conduct, and support of these clinical trials. Published 2010. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2011        PMID: 20456085      PMCID: PMC3405735          DOI: 10.1111/j.1399-5448.2010.00657.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  28 in total

1.  Progressive beta cell failure in type 2 diabetes mellitus of youth.

Authors:  Neslihan Gungor; Silva Arslanian
Journal:  J Pediatr       Date:  2004-05       Impact factor: 4.406

2.  Short-term insulin therapy in adolescents with type 2 diabetes mellitus.

Authors:  E A C Sellers; H J Dean
Journal:  J Pediatr Endocrinol Metab       Date:  2004-11       Impact factor: 1.634

3.  Recruitment and retention of Latino adolescents to a research study: lessons learned from a randomized clinical trial.

Authors:  Antonia M Villarruel; Loretta S Jemmott; John B Jemmott; Brenda L Eakin
Journal:  J Spec Pediatr Nurs       Date:  2006-10       Impact factor: 1.260

4.  Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates.

Authors:  Rola Saad; Neslihan Gungor; Silva Arslanian
Journal:  Pediatr Diabetes       Date:  2005-06       Impact factor: 4.866

5.  Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates.

Authors:  M H Tamaroff; R S Festa; A R Adesman; G A Walco
Journal:  J Pediatr       Date:  1992-05       Impact factor: 4.406

6.  Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?

Authors:  Neslihan Gungor; Fida Bacha; Rola Saad; Janine Janosky; Silva Arslanian
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

7.  Recruiting and retaining young, sedentary, hypertension-prone African American women in a physical activity intervention study.

Authors:  Beth A Staffileno; Lola A Coke
Journal:  J Cardiovasc Nurs       Date:  2006 May-Jun       Impact factor: 2.083

8.  The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus.

Authors:  O Pinhas-Hamiel; D Standiford; D Hamiel; L M Dolan; R Cohen; P S Zeitler
Journal:  Arch Pediatr Adolesc Med       Date:  1999-10

9.  Beta-cell function across the spectrum of glucose tolerance in obese youth.

Authors:  Ram Weiss; Sonia Caprio; Maddalena Trombetta; Sara E Taksali; William V Tamborlane; Riccardo Bonadonna
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

10.  Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study.

Authors:  Michael Gottschalk; Thomas Danne; Aleksandra Vlajnic; José F Cara
Journal:  Diabetes Care       Date:  2007-04       Impact factor: 19.112

View more
  7 in total

Review 1.  Insulin resistance in type 2 diabetic youth.

Authors:  Kara Mizokami-Stout; Melanie Cree-Green; Kristen J Nadeau
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-08       Impact factor: 3.243

Review 2.  Challenging recruitment of youth with type 2 diabetes into clinical trials.

Authors:  Tammy T Nguyen; Vikas Jayadeva; Giovanni Cizza; Rebecca J Brown; Radha Nandagopal; Luisa M Rodriguez; Kristina I Rother
Journal:  J Adolesc Health       Date:  2013-10-23       Impact factor: 5.012

Review 3.  Rising incidence and challenges of childhood diabetes. A mini review.

Authors:  G Cizza; R J Brown; K I Rother
Journal:  J Endocrinol Invest       Date:  2012-05-08       Impact factor: 4.256

4.  Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

Authors:  David J Klein; Tadej Battelino; D J Chatterjee; Lisbeth V Jacobsen; Paula M Hale; Silva Arslanian
Journal:  Diabetes Technol Ther       Date:  2014-07-18       Impact factor: 6.118

5.  Realist-informed review of motivational interviewing for adolescent health behaviors.

Authors:  Christina Mutschler; Erica Naccarato; Jen Rouse; Caitlin Davey; Kelly McShane
Journal:  Syst Rev       Date:  2018-07-27

6.  Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trials.

Authors:  Jack A Sargeant; Emer M Brady; Francesco Zaccardi; Frances Tippins; David R Webb; Vanita R Aroda; Edward W Gregg; Kamlesh Khunti; Melanie J Davies
Journal:  Diabetologia       Date:  2020-06-02       Impact factor: 10.122

7.  A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).

Authors:  Mark D Wheeler; Margarita Barrientos-Perez; Fu-Sung Lo; Bo Liang; Alison Lunsford; Ólöf Thórisdóttir; Nehama Zuckerman-Levin
Journal:  Eur J Pediatr       Date:  2018-07-16       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.